Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 225
Filter
Add more filters

Publication year range
1.
Support Care Cancer ; 30(4): 3187-3200, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34957532

ABSTRACT

PURPOSE: To examine long-term cognitive effects of chemotherapy and identify predictors among women with breast cancer (WBC). PATIENTS AND METHODS: Sixty-nine WBC scheduled to receive chemotherapy, and 64 matched-controls with no cancer, participated. Objective and subjective cognition, total sleep time, nap time, circadian activity rhythms (CAR), sleep quality, fatigue, and depression were measured pre-chemotherapy (Baseline), end of cycle 4 (Cycle-4), and one-year post-chemotherapy (1-Year). RESULTS: WBC showed no change in objective cognitive measures from Baseline to Cycle-4 but significantly improved from both time points to 1-Year. Matched-controls showed an increase in test performance at all time points. WBC had significantly higher self-reported cognitive dysfunction at Cycle-4 and 1-Year compared to baseline and compared to matched-controls. Worse neuropsychological functioning was predicted by less robust CARs (i.e., inconsistent 24 h pattern), worse sleep quality, longer naps, and worse cognitive complaints. Worse subjective cognition was predicted by lower sleep quality and higher fatigue and depressed mood. CONCLUSION: Objective testing showed increases in performance scores from pre- and post-chemotherapy to one year later in WBC, but matched-controls showed an increase in test performance from baseline to Cycle-4 and from Cycle-4 to 1-Year, likely due to a practice effect. The fact that WBC showed no practice effects may reflect a form of learning deficit. Compared with the matched-controls, WBC reported significant worsened cognitive function. In WBC, worse objective and subjective cognitive functioning were predicted by worse sleep and sleep-related behaviors (naps and CAR). Interventions that target sleep, circadian rhythms, and fatigue may benefit cognitive function in WBC.


Subject(s)
Breast Neoplasms , Breast Neoplasms/psychology , Circadian Rhythm , Cognition , Fatigue/epidemiology , Fatigue/etiology , Female , Humans , Quality of Life/psychology , Sleep , Sleep Quality
2.
Psychosom Med ; 81(7): 668-674, 2019 09.
Article in English | MEDLINE | ID: mdl-31145377

ABSTRACT

OBJECTIVE: Older adults are among the most frequent users of emergency departments (EDs). Nonspecific symptoms, such as fatigue and widespread pain, are among the most common symptoms in patients admitted at the ED. Interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) are inflammation biomarkers associated with chronic stress (i.e., dementia caregiving) and nonspecific symptoms. This study aimed to determine whether IL-6 and TNF-α were prospectively associated with ED risk in dementia caregivers (CGs). METHODS: Participants were 85 dementia CGs, who reported during three assessments (3, 9, and 15 months after enrollment) if they had visited an ED for any reason. Cox proportional hazards models were used to examine the relations between resting circulating levels of IL-6 and TNF-α obtained at enrollment and subsequent risk for an ED visit, adjusting for age, sex, use of ED 1 month before enrollment, physical and mental health well-being, body mass index, and CG demands. RESULTS: (log) IL-6 significantly predicted ED visits during the 15-month follow-up (B = 1.96, SE = 0.82, p = .017). For every (log) picogram per milliliter increase in IL-6, the risk of visiting an ED was 7.10 times greater. TNF-α was not associated with subsequent ED visits. Exploratory analyses suggested that CGs with levels of IL-6 above the 80th percentile and experiencing high CG demands were at highest risk of an ED visit. CONCLUSIONS: IL-6 levels and CG demands may be useful for predicting vulnerability for future ED visits. Although further studies should be conducted to replicate and extend these findings, interventions that successfully modify inflammation markers, including the underlying pathophysiology related to stress and/or comorbid illnesses, may be useful in preventing costly and detrimental outcomes in this population.


Subject(s)
Caregivers/statistics & numerical data , Dementia/nursing , Emergency Service, Hospital/statistics & numerical data , Interleukin-6/blood , Patient Acceptance of Health Care/statistics & numerical data , Stress, Psychological/blood , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Tumor Necrosis Factor-alpha/blood
3.
BMC Geriatr ; 19(1): 18, 2019 01 22.
Article in English | MEDLINE | ID: mdl-30669980

ABSTRACT

BACKGROUND: Caregivers of a family member with a chronic disability or illness such as dementia are at increased risk for chronic disease. There are many factors that contribute to dementia caregiver vulnerability and these factors can be challenging to assess in clinical settings. Self-rated health (SRH) is an independent measure of survival and physical health in the elderly. As an inclusive measure of health, SRH has been proposed as a reliable way to assess a patient's general health in primary care. Therefore, we sought to identify determinants of poor/fair SRH versus categories of at least good SRH in informal caregivers. METHODS: In a cross-sectional study, we examined 134 elderly (≥55 years) providing in-home care for a spouse with dementia who rated their own health with a single-item question: "In general, would you say your health is excellent, very good, good, fair or poor?". In a multivariable model, we compared caregivers with poor/fair SRH to those with good, very good, or excellent SRH on demographics, health characteristics (health behaviors, physical health indicators, psychosocial factors) and caregiving-specific stress (a composite index/total of four caregiving-specific stressors: years of caregiving, dementia severity, care recipient functional impairment and perceived caregiver burden). RESULTS: Compared with caregivers who rated their own health as either good (31.3%), very good (38.8%) or excellent (14.2%), caregivers with poor/fair SRH (15.7%) were more likely to have lower physical function and total greater caregiving-specific stress. More years of caregiving, severe dementia and care recipient functional impairment, but not perceived caregiver burden, were also more likely among caregivers with poor/fair SRH. Additionally, high negative affect and low positive affect were more likely in caregivers with poor/fair vs. good or excellent and very good or excellent SRH, respectively. CONCLUSIONS: Caregivers with poor/fair SRH were characterized by higher levels of medical comorbidity, low physical function, high negative, but low positive affect and longer duration of caregiving, as well as more severe dementia and greater functional impairment of the care recipient. These findings suggest that caregivers need to be more closely evaluated and targeted for preventive interventions in clinical practice. TRIAL REGISTRATION: ClinicalTrials.gov registration number: NCT02317523 .


Subject(s)
Adaptation, Psychological , Caregivers/psychology , Dementia/psychology , Health Status , Self Efficacy , Spouses/psychology , Aged , Aged, 80 and over , Cross-Sectional Studies , Dementia/therapy , Female , Humans , Male , Middle Aged
4.
Psychosom Med ; 79(9): 971-973, 2017.
Article in English | MEDLINE | ID: mdl-28976443

ABSTRACT

The new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition defines somatic symptom and related disorders as long-standing somatic symptoms that are associated with disproportionate thoughts, feelings, and behaviors, irrespective of whether or not a medical cause for these symptoms can be determined. In this Special Section of Psychosomatic Medicine, several articles address diagnostic issues and the central nervous system correlates of somatic symptom and related disorder and document new developments in its treatment.


Subject(s)
Medically Unexplained Symptoms , Somatoform Disorders/diagnosis , Humans
5.
Psychosom Med ; 79(7): 735-741, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28640179

ABSTRACT

OBJECTIVE: Elevated blood pressure is a significant public health concern, particularly given its association with cardiovascular disease risk, including stroke. Caring for a loved one with Alzheimer disease has been associated with physical health morbidity, including higher blood pressure. Engagement in adaptive coping strategies may help prevent blood pressure elevation in this population. This 5-year longitudinal study examined whether greater participation in pleasant leisure activities was associated with reduced blood pressure in caregivers. METHODS: Participants were 126 in-home spousal Alzheimer's caregivers (M [SD] age = 74.2 [7.9] years) that completed five yearly assessments. Linear mixed-effects models analysis was used to examine the longitudinal relationship between pleasant leisure activities and caregivers' blood pressure, after adjusting for demographic and health characteristics. RESULTS: Greater engagement in pleasant leisure activities was associated with reduced mean arterial blood pressure (B = -0.08, SE = 0.04, p = .040). Follow-up analyses indicated that engagement in activities was significantly associated with reduced diastolic (B = -0.07, SE = 0.03, p = .030) but not systolic blood pressure (B = -0.10, SE = 0.06, p = .114). In addition, mean arterial blood pressure was significantly reduced when caregiving duties ended because of placement of care recipients in nursing homes (B = -3.10, SE = 1.11, p = .005) or death of the care recipient (B = -2.64, SE = 1.14, p = .021). CONCLUSIONS: Greater engagement in pleasant leisure activities was associated with lowered caregivers' blood pressure over time. Participation in pleasant leisure activities may have cardiovascular health benefits for Alzheimer's caregivers.


Subject(s)
Alzheimer Disease/nursing , Blood Pressure/physiology , Caregivers/psychology , Leisure Activities/psychology , Spouses/psychology , Aged , Aged, 80 and over , Female , Humans , Longitudinal Studies , Male , Middle Aged
6.
J Behav Med ; 38(3): 407-15, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25533643

ABSTRACT

Depression adversely predicts prognosis in individuals with symptomatic heart failure. In some clinical populations, spiritual wellness is considered to be a protective factor against depressive symptoms. This study examined associations among depressive symptoms, spiritual wellbeing, sleep, fatigue, functional capacity, and inflammatory biomarkers in 132 men and women with asymptomatic stage B heart failure (age 66.5 years ± 10.5). Approximately 32 % of the patients scored ≥10 on the Beck Depression Inventory, indicating potentially clinically relevant depressive symptoms. Multiple regression analysis predicting fewer depressive symptoms included the following significant variables: a lower inflammatory score comprised of disease-relevant biomarkers (p < 0.02), less fatigue (p < 0.001), better sleep (p < 0.04), and more spiritual wellbeing (p < 0.01) (overall model F = 26.6, p < 0.001, adjusted R square = 0.629). Further analyses indicated that the meaning (p < 0.01) and peace (p < 0.01) subscales, but not the faith (p = 0.332) subscale, of spiritual wellbeing were independently associated with fewer depressive symptoms. Interventions aimed at increasing spiritual wellbeing in patients lives, and specifically meaning and peace, may be a potential treatment target for depressive symptoms asymptomatic heart failure.


Subject(s)
Depressive Disorder/psychology , Heart Failure/psychology , Quality of Life/psychology , Religion and Psychology , Spirituality , Activities of Daily Living/classification , Activities of Daily Living/psychology , Adult , Aged , Biomarkers , Depressive Disorder/complications , Depressive Disorder/diagnosis , Fatigue/complications , Female , Heart Failure/classification , Heart Failure/diagnosis , Humans , Male , Middle Aged , Multivariate Analysis , Personality Inventory , Psychiatric Status Rating Scales
7.
J Sleep Res ; 23(1): 84-93, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24033699

ABSTRACT

Endothelial function typically precedes clinical manifestations of cardiovascular disease and provides a potential mechanism for the associations observed between cardiovascular disease and sleep quality. This study examined how subjective and objective indicators of sleep quality relate to endothelial function, as measured by brachial artery flow-mediated dilation (FMD). In a clinical research centre, 100 non-shift working adults (mean age: 36 years) completed FMD testing and the Pittsburgh Sleep Quality Index, along with a polysomnography assessment to obtain the following measures: slow wave sleep, percentage rapid eye movement (REM) sleep, REM sleep latency, total arousal index, total sleep time, wake after sleep onset, sleep efficiency and apnea-hypopnea index. Bivariate correlations and follow-up multiple regressions examined how FMD related to subjective (i.e., Pittsburgh Sleep Quality Index scores) and objective (i.e., polysomnography-derived) indicators of sleep quality. After FMD showed bivariate correlations with Pittsburgh Sleep Quality Index scores, percentage REM sleep and REM latency, further examination with separate regression models indicated that these associations remained significant after adjustments for sex, age, race, hypertension, body mass index, apnea-hypopnea index, smoking and income (Ps < 0.05). Specifically, as FMD decreased, scores on the Pittsburgh Sleep Quality Index increased (indicating decreased subjective sleep quality) and percentage REM sleep decreased, while REM sleep latency increased (Ps < 0.05). Poorer subjective sleep quality and adverse changes in REM sleep were associated with diminished vasodilation, which could link sleep disturbances to cardiovascular disease.


Subject(s)
Perception/physiology , Regional Blood Flow/physiology , Sleep Wake Disorders/physiopathology , Sleep, REM/physiology , Vasodilation/physiology , Adult , Body Mass Index , Brachial Artery/pathology , Brachial Artery/physiology , Cardiovascular Diseases/complications , Cardiovascular Diseases/physiopathology , Female , Humans , Hypertension/complications , Hypertension/physiopathology , Male , Middle Aged , Polysomnography , Sleep Apnea Syndromes/complications , Sleep Apnea Syndromes/physiopathology , Sleep Wake Disorders/complications , Sleep Wake Disorders/psychology , Smoking , Social Class , Stress, Psychological , Young Adult
8.
Int J Behav Med ; 21(5): 843-50, 2014.
Article in English | MEDLINE | ID: mdl-24114717

ABSTRACT

BACKGROUND: Depressive symptoms and fatigue frequently overlap in clinical samples and the general population. The link of depressive symptoms and fatigue with increased risk of cardiovascular disease has been partly explained by shared biological mechanisms including sympathetic overactivity. Prolonged sympathetic overactivity downregulates the responsiveness of the ß-adrenergic receptor (ß-AR), a receptor that mediates several end-organ sympathetic responses. PURPOSE: The authors studied whether depression and fatigue are related to reduced ß-AR responsiveness within the human body (in vivo) in an ethnically diverse sample of African and Caucasian Americans. METHODS: The chronotropic25 dose (CD25) was used to determine in vivo ß-AR responsiveness in 93 healthy participants. Psychometric measures included the Center of Epidemiological Studies-Depression Scale and the Multidimensional Fatigue Symptom Inventory. RESULTS: Hierarchical regression analyses (adjusted for age, gender, body mass index, blood pressure, smoking, and ethnicity) revealed that mental fatigue was significantly related to reduced ß-AR responsiveness (i.e., higher CD25 values) in the whole sample. Moderation analyses indicated significant ethnicity × depression/fatigue interactions. Depressive symptoms, total fatigue, emotional fatigue, mental fatigue, and physical fatigue were related to reduced ß-AR responsiveness in Caucasian American but not in African Americans. CONCLUSIONS: Our findings suggest that symptoms of depression and fatigue are related to decreased in vivo ß-AR responsiveness in Caucasian Americans. The lack of this association in African Americans highlights the importance for considering ethnicity as a potential moderator in research focusing on associations between psychological variables and cardiovascular function.


Subject(s)
Black or African American/psychology , Depression/metabolism , Mental Fatigue/metabolism , Receptors, Adrenergic, beta/metabolism , White People/psychology , Adult , Depression/psychology , Fatigue/metabolism , Fatigue/psychology , Female , Humans , Male , Mental Fatigue/psychology , Middle Aged , Regression Analysis
9.
Behav Sleep Med ; 12(5): 358-72, 2014 Sep 03.
Article in English | MEDLINE | ID: mdl-24156281

ABSTRACT

This article examines the longitudinal relation between positive affect (PA) and sleep in 126 spousal Alzheimer's disease caregivers. Caregivers underwent 4 yearly assessments for the Positive and Negative Affect Schedule, the self-rated Pittsburgh Sleep Quality Index, and actigraphy to objectify nighttime total sleep time, wake after sleep onset, and percentage of sleep. Increased levels of PA and a greater positivity (i.e., positive-to-negative affect) ratio were significantly associated with better subjective sleep over the entire study period. Yearly increases in PA-even when controlling for negative affect (NA)-and in the positivity ratio were also associated with better subjective sleep. PA and actigraphy measures showed no significant relations. Increased PA is longitudinally associated with better sleep in dementia caregivers largely independent of NA.


Subject(s)
Affect , Alzheimer Disease/nursing , Caregivers/psychology , Sleep Wake Disorders/etiology , Sleep , Stress, Psychological/etiology , Actigraphy , Aged , Aged, 80 and over , Female , Humans , Independent Living , Longitudinal Studies , Male , Middle Aged , Self Report
10.
Clin Hypertens ; 30(1): 14, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38822391

ABSTRACT

BACKGROUND: Obstructive sleep apnea (OSA) is associated with high blood pressure that responds poorly to usual antihypertensive therapy. METHODS AND RESULTS: Forty-one subjects with OSA had 25% higher plasma norepinephrine and 42% higher epinephrine measured every 2 h over 24 h than 20 control subjects. They also excreted more sodium during sleep. This suggested that that a sympatholytic would be a more successful antihypertensive than a diuretic. To test this hypothesis we treated a second group of 23 hypertensive apneics with placebo, 6 weeks of the sympatholytic guanfacine and 6 weeks of hydrochlorothiazide in a crossover study. Guanfacine lowered 24-hour blood pressure by 9.6/6.7 mmHg, more than the 5.4/2.9 mmHg effect of hydrochlorothiazide (P < 0.05). Nighttime systolic blood pressure dipping was poor at 6.6 ± 1.8%. Hydrochlorothiazide did not alter blood pressure dipping but guanfacine improved dipping to 9.1 ± 1.2%, a better result (P = 0.03) than from the diuretic. Central aortic pressure by pulse wave analysis was 120/84 mmHg on hydrochlorothiazide and 109/72 on guanfacine, (P < 0.05). Guanfacine, but not hydrochlorothiazide, improved baroreflex sensitivity, heart rate variability and flow mediated vascular dilation, suggesting that decreasing the elevated sympathetic nerve activity of obstructive sleep apnea returned vascular function toward normal. CONCLUSIONS: OSA is the most common condition associated with antihypertensive treatment failure. It increased sympathetic nerve activity day and night. Drugs that block sympathetic nerve function are not among the 4 most commonly recommended classes of antihypertensives but diuretics are. Sympatholytic therapy was superior to diuretic treatment for hypertension associated with sleep apnea. TRIAL REGISTRATION: NCT, NCT02699125, Registered 26 February 2016 - Retrospectively registered, https://clinicaltrials.gov/study/NCT02699125 .

11.
Behav Sleep Med ; 11(3): 189-206, 2013.
Article in English | MEDLINE | ID: mdl-23205513

ABSTRACT

This study examined the longitudinal relation between health-related quality of life (HR-QOL) and subjective and objective sleep quality in 166 women with newly diagnosed Stage-1 through Stage-3 breast cancer, who were scheduled to receive ≥ 4 cycles of adjuvant/neoadjuvant chemotherapy. HR-QOL was assessed with the Medical Outcomes Study 36-item Short Form, Physical Component Scale (PCS), and Mental Component Scale (MCS) scores; subjective sleep was assessed with the Pittsburgh Sleep Quality Index; and objective sleep was measured with actigraphy. Data were collected before starting chemotherapy and during the last week of Cycle 4 of chemotherapy. Patients reported poor HR-QOL and poor sleep quality before and during chemotherapy. Short sleep time and long naps were recorded at both time points. The MCS score was related to reports of poor sleep, but not to recorded sleep; worse PCS scores were associated with reports of poor sleep and less recorded naptime, suggesting sleep plays an important role in cancer patients' HR-QOL.


Subject(s)
Breast Neoplasms/psychology , Health Status , Quality of Life/psychology , Sleep Initiation and Maintenance Disorders/psychology , Actigraphy , Adult , Aged , Aged, 80 and over , Breast Neoplasms/complications , Breast Neoplasms/drug therapy , Breast Neoplasms/physiopathology , Chemotherapy, Adjuvant/adverse effects , Female , Humans , Longitudinal Studies , Middle Aged , Prescription Drugs/therapeutic use , Sleep Initiation and Maintenance Disorders/chemically induced , Sleep Initiation and Maintenance Disorders/complications , Sleep Initiation and Maintenance Disorders/drug therapy , Sleep Initiation and Maintenance Disorders/physiopathology
12.
Psychosom Med ; 74(3): 271-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22366585

ABSTRACT

OBJECTIVE: Several stress-related states and conditions that are considered to involve sympathetic overactivation are accompanied by increased circulating levels of inflammatory immune markers. Prolonged sympathetic overactivity involves increased stimulation of the ß-adrenergic receptor (ß-AR). Although prior research suggests that one mechanism by which sympathetic stimulation may facilitate inflammation is via ß-AR activation, little work has focused on the relationship between circulating inflammatory immune markers and ß-AR function within the human body (in vivo). We examined whether decreased ß-AR sensitivity, an indicator of prolonged ß-adrenergic overactivation and a physiological component of chronic stress, is related to elevated levels of inflammatory immune markers. METHODS: Ninety-three healthy participants aged 19 to 51 years underwent the chronotropic 25 dose isoproterenol test to determine in vivo ß-AR function. Circulating levels of C-reactive protein, interleukin 6, and soluble tumor necrosis factor receptor 1 were determined. RESULTS: ß-AR sensitivity was lower in people with higher C-reactive protein concentrations (r = 0.326, p = .003). That relationship remained significant after controlling for sociodemographic and health variables such as age, sex, ethnicity, body mass index, mean arterial blood pressure, heart rate, leisure-time exercise, and smoking status. No significant relationship was found between chronotropic 25 dose and interleukin 6 or soluble tumor necrosis factor receptor 1. CONCLUSIONS: This study demonstrates a link between in vivo ß-adrenergic receptor function and selected circulating inflammatory markers (CRP) in humans. Future studies in specific disease states may be promising.


Subject(s)
Adrenergic beta-Agonists , C-Reactive Protein/metabolism , Inflammation/diagnosis , Isoproterenol , Receptors, Adrenergic, beta/physiology , Adrenergic beta-Agonists/administration & dosage , Adult , Animals , Biomarkers/blood , Cross-Sectional Studies , Female , Health Status , Heart Rate/drug effects , Heart Rate/physiology , Humans , Inflammation/blood , Interleukin-6/blood , Isoproterenol/administration & dosage , Linear Models , Male , Middle Aged , Rats , Receptors, Tumor Necrosis Factor, Type I/blood , Young Adult
13.
Psychosom Med ; 74(2): 214-20, 2012.
Article in English | MEDLINE | ID: mdl-22286846

ABSTRACT

OBJECTIVE: To estimate the glomerular filtration rate (GFR) in relation to the chronic stress of dementia caregiving and major transitions in the caregiving situation. METHODS: We longitudinally assessed 119 people serving as caregivers for their spouses with Alzheimer's disease and 58 noncaregiving controls for a period of up to 3 years (mean of 2.8 assessments per participant). At baseline, the mean (standard deviation [SD]) age of all participants was 74.5 (7.5) years. Random regression models with fixed and time-variant effects for psychosocial factors, risk factors of chronic kidney disease, and caregiving transitions were used to evaluate changes over time in estimated GFR. RESULTS: The change in GFR did not differ between caregivers and controls during follow-up (p = .77). Further analyses revealed that GFR declined disproportionately after placement of the spouse in a nursing home at 3 months after placement (-4.9 [2.2] mL/min per 1.73 m(2); p = .03). Post hoc analyses showed that this effect was stronger in caregivers with hypertension compared with those without hypertension (-5.7 [3.1] versus -2.4 [3.4] mL/min per 1.73 m(2)), as well as in caregivers with diastolic blood pressure (BP) levels at 1 SD above the mean than in those with diastolic BP levels at 1 SD below the mean (-8.3 [2.9] versus -1.4 [2.7] mL/min per 1.73 m(2)). CONCLUSIONS: Kidney function did not differ between caregivers and controls over time. However, GFR had impaired at 3 months after a major caregiving transition. Because the effect of placement of the spouse with Alzheimer's disease on the decline in GFR was moderated by BP, it might be confined to caregivers who experience increased sympathetic activation after placement.


Subject(s)
Caregivers/psychology , Dementia/psychology , Glomerular Filtration Rate/physiology , Kidney Diseases/epidemiology , Life Change Events , Stress, Psychological/epidemiology , Aged , Aged, 80 and over , Bereavement , Blood Pressure/physiology , Caregivers/statistics & numerical data , Case-Control Studies , Dementia/nursing , Female , Health Status , Humans , Hypertension/epidemiology , Hypertension/physiopathology , Kidney Diseases/physiopathology , Linear Models , Longitudinal Studies , Male , Middle Aged , Nursing Homes , Regression Analysis , Risk Factors , Spouses/psychology , Stress, Psychological/physiopathology , Time Factors
14.
Brain Behav Immun ; 26(5): 706-13, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22406004

ABSTRACT

Fatigue and sleep disturbances are two of the most common and distressing symptoms reported by cancer patients. Fatigue and sleep are also correlated with each other. While fatigue has been reported to be associated with some inflammatory markers, data about the relationship between cancer-related sleep disturbances and inflammatory markers are limited. This study examined the relationship between fatigue and sleep, measured both subjectively and objectively, and inflammatory markers in a sample of breast cancer patients before and during chemotherapy. Fifty-three women with newly diagnosed stage I-III breast cancer scheduled to receive at least four 3-week cycles of chemotherapy participated in this longitudinal study. Fatigue was assessed with the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF), sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI) and objective sleep was measured with actigraphy. Three inflammatory markers were examined: Interleukin-6 (IL-6), Interleukin-1 receptor antagonist (IL-1RA) and C-reactive protein (CRP). Data were collected before (baseline) and during cycle 1 and cycle 4 of chemotherapy. Compared to baseline, more fatigue was reported, levels of IL-6 increased and IL-1RA decreased during chemotherapy. Reports of sleep quality remained poor. Mixed model analyses examining changes from baseline to each treatment time point revealed overall positive relationships between changes in total MFSI-SF scores and IL-6, between changes in total PSQI scores and IL-6 and IL-1RA, and between total wake time at night and CRP (all p's<0.05). These relationships suggest that cancer-related fatigue and sleep disturbances may share common underlying biochemical mechanisms.


Subject(s)
Antineoplastic Agents/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/psychology , Fatigue/etiology , Inflammation Mediators/metabolism , Sleep/physiology , Adult , Aged , Antineoplastic Agents/adverse effects , Breast Neoplasms/pathology , C-Reactive Protein/metabolism , Cytokines/biosynthesis , Data Interpretation, Statistical , Disease Progression , Female , Humans , Interleukin 1 Receptor Antagonist Protein/blood , Interleukin-6/blood , Longitudinal Studies , Middle Aged , Motor Activity/physiology , Sleep Wake Disorders/complications
15.
Stress ; 15(2): 121-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21790484

ABSTRACT

The stress associated with providing care for a spouse diagnosed with Alzheimer's disease can have adverse effects on cardiovascular health. One potential explanation is that chronic caregiving stress may contribute to the development of atherosclerosis. The purpose of this study was to determine whether the duration that one has provided care is associated with the degree of atherosclerotic burden, as measured by carotid artery intima-media thickness (IMT). One hundred and ten Alzheimer caregivers [mean age 74 ± 8 (SD) years, 69% female] underwent in-home assessment of carotid artery IMT via B-mode ultrasonography. Data regarding medical history, blood pressure, and multiple indicators of caregiving stress were also collected. Multiple regression indicated that duration of care was positively associated with IMT measured in the internal/bifurcation segments of the carotid artery (ß = 0.202, p = 0.044) independent of risk factors such as age, gender, body mass index, smoking history, sleep quality, hypertension status, and caregiving stressors. Duration of care was positively associated with IMT in the common carotid artery, but the relationship was not significant. These findings provide more evidence of the link between chronic caregiving stress and cardiovascular disease and indicate that enduring the experience of caregiving over a period of years might be associated with atherosclerotic burden.


Subject(s)
Alzheimer Disease/therapy , Caregivers , Carotid Intima-Media Thickness , Stress, Psychological/diagnostic imaging , Aged , Aged, 80 and over , Aging/physiology , Atherosclerosis/physiopathology , Blood Pressure/physiology , Carotid Artery Diseases/diagnostic imaging , Carotid Artery, Common/diagnostic imaging , Female , Humans , Hypertension/diagnostic imaging , Hypertension/physiopathology , Male , Middle Aged , Risk Factors
16.
Gerontology ; 58(4): 354-65, 2012.
Article in English | MEDLINE | ID: mdl-22133914

ABSTRACT

BACKGROUND: Providing care to a spouse with Alzheimer's disease (AD) may contribute to cardiovascular disease (CVD). The acute phase reactant C-reactive protein (CRP) is a well-established biomarker of an increased CVD risk. OBJECTIVE: To investigate the hypothesis that dementia caregiving is associated with elevated circulating levels of CRP and possibly other biomarkers of CVD risk. METHODS: We examined 118 elderly spousal Alzheimer caregivers and 51 noncaregiving controls about once a year for up to 3 years. Random regression models with fixed and time-variant effects for a range of covariates known to affect biomarker levels were used to evaluate changes in CRP and in 12 additional measures of inflammation, cellular adhesion, endothelial function, and hemostasis in relation to caregiving status, years of caregiving, and major transitions in the caregiving situation. RESULTS: During the study period, longer duration of caregiving was associated with elevated CRP levels (p = 0.040) and caregivers showed greater tumor necrosis factor (TNF)-α levels than controls (p = 0.048). Additionally, 3 months after the death of the AD spouse, caregivers showed a significant drop in CRP levels (p = 0.003) and levels of soluble intercellular adhesion molecule (sICAM)-1 (p = 0.008). CONCLUSION: Duration of caregiving and being a caregiver per se were both associated with chronic low-grade inflammation as indicated by elevated CRP and TNF-α levels, respectively. Conversely, death of the AD spouse was associated with lower CRP and sICAM-1 levels. The findings indicate that chronic caregiving of those with dementia may result in increased inflammation and, thereby, possibly increased CVD risk.


Subject(s)
Alzheimer Disease/therapy , C-Reactive Protein/metabolism , Cardiovascular Diseases/blood , Cardiovascular Diseases/etiology , Caregivers/psychology , Aged , Aged, 80 and over , Biomarkers/blood , Cardiovascular Diseases/psychology , Case-Control Studies , Cytokines/blood , Female , Humans , Longitudinal Studies , Male , Middle Aged , Risk Factors , Stress, Psychological
17.
J Appl Biobehav Res ; 17(1): 59-78, 2012 Mar 01.
Article in English | MEDLINE | ID: mdl-22773899

ABSTRACT

It is unknown if fatigue measures like the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF; Stein, Jacobsen, Blanchard, & Thors, 2004) appropriately describe fatigue in Hispanics or if acculturation plays a role in fatigue. This study compared fatigue in community samples of Hispanics and Anglos. The MFSI-SF and pertinent questionnaires were administered to adults in San Diego County via telephone survey. Some differences in fatigue were observed in initial comparisons between Hispanics and Anglos, including when acculturation was considered. When age and education were controlled, Hispanics reported less general fatigue than Anglos, regardless of acculturation status, p = < .01. Exploratory factor analyses indicate that the MFSI-SF general-fatigue subscale was problematic for Hispanics. Implications, limitations, and future directions are discussed.

18.
Breast Cancer Res Treat ; 130(2): 579-86, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21656272

ABSTRACT

After successful treatment of early breast cancer, many women still report pain symptoms, and attribute them to the previous illness or its treatment. However, knowledge about the long-term course of pain in breast cancer is limited. Baseline assessment included 3,088 women who received a breast cancer diagnosis on average 2 years prior to enrollment, and who completed typical medical treatments. After 4 years, a subsample of 2,160 recurrence-free women (70%) was re-assessed. The major outcome variable was the composite index for general pain symptoms. Over the 4-year course, a slight but significant increase in pain was reported. If only medical variables were examined, a triple interaction between surgery type, breast cancer stage, and time indicated that pain scores increased in most subgroups, while they decreased in stage II women after mastectomy and stage III women after lumpectomy. Using a regression analytical approach, psychological and other variables added significantly to the prediction of pain persistence. Regression analysis revealed that pain symptoms increased in those women taking tamoxifen at baseline, in those reporting depression at baseline or stressful life events during the first 12 months after enrollment. Exercise at baseline had a beneficial effect on pain recovery. The persistence or increase of pain symptoms in women surviving breast cancer is associated with some medical factors (surgery type, tamoxifen use), but also with psychological factors. Pain should be a standard outcome variable in the evaluation of cancer treatment programs.


Subject(s)
Breast Neoplasms/physiopathology , Pain/physiopathology , Survivors , Adult , Analysis of Variance , Antineoplastic Agents, Hormonal/adverse effects , Antineoplastic Agents, Hormonal/therapeutic use , Breast Neoplasms/therapy , Depression/complications , Female , Humans , Linear Models , Longitudinal Studies , Mastectomy/adverse effects , Middle Aged , Pain/epidemiology , Pain/psychology , Surveys and Questionnaires , Tamoxifen/adverse effects , Tamoxifen/therapeutic use
19.
Psychosom Med ; 73(5): 360-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21636660

ABSTRACT

OBJECTIVE: This systematic and quantitative review evaluates the literature on associations between depressed mood and flow-mediated dilation (FMD), a measure of endothelial function, in adults. METHODS: Published English-language articles (through December 2010) were identified from literature searches, assessed for data extraction, and evaluated for quality. RESULTS: The literature includes cross-sectional (n = 9) and retrospective examinations (n = 3) of how FMD correlates with clinical or subclinical depression in healthy adults and cardiovascular patients (total N across 12 studies = 1491). FMD was assessed using a variety of methodologies. Samples were predominately older white and Asian subjects with higher socioeconomic status. In eight of the 12 articles selected for this review, at least one significant inverse association was noted between depressed mood and FMD, with primarily moderate effect sizes. The overall meta-analysis (random-effects model) revealed a combined effect size of correlation coefficient r = 0.19 (95% confidence interval = 0.08-0.29, p = .001). Significant combined effects were found for subgroups of studies that a) received better quality ratings (r = 0.29), b) examined patients with cardiovascular disease or with cardiovascular disease risk factors/comorbidity (r = 0.29), c) used maximum vasodilation to quantify FMD (r = 0.27), and d) assessed samples that had a mean age of 55 years and older (r = 0.15). CONCLUSIONS: Diverse studies support the inverse correlation between depressed mood and endothelial function, as measured by FMD. This literature would be strengthened by prospective studies, increased methodological consistency in FMD testing, and broader sampling (e.g., African Americans, younger age, lower socioeconomic status).


Subject(s)
Cardiovascular Diseases/physiopathology , Depression/physiopathology , Endothelium, Vascular/physiopathology , Vasodilation/physiology , Adult , Cross-Sectional Studies , Female , Humans , Hyperemia , Male , Retrospective Studies , Social Class
20.
Psychosom Med ; 73(2): 206-13, 2011.
Article in English | MEDLINE | ID: mdl-21217096

ABSTRACT

OBJECTIVES: To test the hypothesis that those who provide care for a spouse diagnosed with Alzheimer's disease would have increased prevalence of carotid artery plaque compared with noncaregiving controls and that prolonged sympathoadrenal arousal to acute stress would relate to this difference. Providing care for a spouse with Alzheimer's disease has been associated with an increased risk of coronary heart disease, potentially due to the impact of caregiving stress on the atherosclerotic disease process. METHODS: Participants were 111 spousal caregivers (74 ± 8 years of age; 69% women) to patients with Alzheimer's disease and 51 noncaregiving controls (75 ± 6 years of age; 69% women). Inhome assessment of carotid artery plaque via B-mode ultrasonography was conducted. Plasma catecholamine response to an acute speech stressor task was also measured. RESULTS: Logistic regression indicated that caregiving status (i.e., caregiver versus noncaregiver) was associated significantly with a 2.2 times greater odds for the presence of plaque independent of other risk factors of atherosclerosis (95% confidence interval, 1.01-4.73, p = .048). Decreased recovery to basal levels of epinephrine after a psychological stress task was associated significantly with the presence of plaque in caregivers, but not in noncaregivers. Norepinephrine recovery post stressor was not associated with plaque in either group. CONCLUSIONS: Caregivers had a higher frequency of carotid plaque compared with noncaregivers. Poorer epinephrine recovery after acute stress was associated with the presence of plaque in caregivers but not in noncaregivers. A prolonged sympathoadrenal response to acute stress might enhance the development of atherosclerosis in chronically stressed Alzheimer caregivers.


Subject(s)
Alzheimer Disease/therapy , Arousal/physiology , Caregivers/psychology , Carotid Artery Diseases/physiopathology , Coronary Artery Disease/epidemiology , Plaque, Atherosclerotic/physiopathology , Stress, Psychological/physiopathology , Adult , Aged , Alzheimer Disease/nursing , Alzheimer Disease/psychology , Body Mass Index , Caregivers/statistics & numerical data , Carotid Artery Diseases/diagnostic imaging , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/physiopathology , Epinephrine/physiology , Female , Humans , Male , Norepinephrine/physiology , Plaque, Atherosclerotic/diagnostic imaging , Risk Factors , Stress, Psychological/psychology , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL